Provided by Tiger Trade Technology Pte. Ltd.

iRadimed

85.40
+0.10000.12%
Post-market: 85.400.00000.00%19:30 EDT
Volume:119.45K
Turnover:10.22M
Market Cap:1.09B
PE:47.71
High:86.27
Open:86.14
Low:84.53
Close:85.30
52wk High:107.90
52wk Low:70.80
Shares:12.79M
Float Shares:8.31M
Volume Ratio:0.73
T/O Rate:1.44%
Dividend:0.77
Dividend Rate:0.90%
EPS(TTM):1.79
EPS(LYR):1.75
ROE:23.52%
ROA:15.56%
PB:10.73
PE(LYR):48.80

Loading ...

IRadimed Corp - Sees Q3 2026 Revenue $23 Mln-$24.50 Mln, Non-Gaap Diluted EPS $0.54-$0.59

THOMSON REUTERS
·
Jul 31

IRadimed Corporation Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 31

IRadimed Q2 EPS USD 0.41

THOMSON REUTERS
·
Jul 31

IRadimed Q2 Revenue USD 20.5 Million

THOMSON REUTERS
·
Jul 31

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 31

Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD)

Simply Wall St.
·
Jul 29

Iradimed Schedules Conference Call to Discuss Second-quarter 2026 Results

Reuters
·
Jul 25

Iradimed Shareholders Elect Five Directors at Annual Meeting

Reuters
·
Jun 24

Independent Director Hilda Scharen-Guivel Sold A Bunch Of Shares In IRADIMED

Simply Wall St.
·
Jun 07

IRadimed Director Hilda Scharen-Guivel disposes of 3,000 common shares for $285,000

Reuters
·
Jun 05

IRadimed CEO Roger E. Susi disposes of 2,500 common shares worth $226,204.11

Reuters
·
Jun 03

IRadimed CEO Roger E. Susi disposes of common shares worth $689,981.05

Reuters
·
May 29

IRadimed CEO Roger E. Susi disposes 7,500 shares worth $659,902.20

Reuters
·
May 21

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
May 20

IRadimed CEO Roger E. Susi disposes 7,500 shares for $635,776

Reuters
·
May 14

The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why

Simply Wall St.
·
May 11

IRadimed CEO Roger E. Susi sells USD 638,299 common shares

Reuters
·
May 07

Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD?

Simply Wall St.
·
May 04

Stock Track | iRadimed Soars 5.20% Intraday on Strong Q1 Earnings Beat and Successful New Product Launch

Stock Track
·
May 02

Stock Track | iRadimed Plummets 7.77% Intraday Despite Q1 Earnings Beat on Guidance Concerns

Stock Track
·
May 01